EHMT2 and cancer: Another well described mechanism by which G9a contributes to cancer biology is through both transcriptional repression of genes negatively regulated by hypoxia as well as activating methylation of pro-tumorigenic hypoxic factors, such as Pontin [30, 67, 68].